Combined brachytherapy and external beam radiotherapy without adjuvant androgen deprivation therapy for high-risk prostate cancer
Open Access
- 9 January 2014
- journal article
- Published by Springer Nature in Radiation Oncology
- Vol. 9 (1) , 13
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Comparison of Preplanning and Intraoperative Planning for I-125 Prostate BrachytherapyJapanese Journal of Clinical Oncology, 2013
- Predictors of distant metastasis after combined HDR brachytherapy and external beam radiation for prostate cancerJournal of Contemporary Brachytherapy, 2013
- Tri-Modality therapy with I-125 brachytherapy, external beam radiation therapy, and short- or long-term hormone therapy for high-risk localized prostate cancer (TRIP): study protocol for a phase III, multicenter, randomized, controlled trialBMC Cancer, 2012
- 70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized TrialInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyThe Lancet Oncology, 2010
- Relationship between prostate cancer mortality and number of unfavourable risk factors in men treated with definitive brachytherapyBJU International, 2010
- Secondary Therapy, Metastatic Progression, and Cancer-Specific Mortality in Men with Clinically High-Risk Prostate Cancer Treated with Radical ProstatectomyEuropean Urology, 2008
- Androgen Deprivation Therapy Does Not Impact Cause-Specific or Overall Survival in High-Risk Prostate Cancer Managed With Brachytherapy and Supplemental External BeamInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 GyJournal of Clinical Oncology, 2006
- Acute urinary morbidity following I-125 prostate brachytherapyInternational Journal of Clinical Oncology, 2005